SynthesisBMC pregnancy and childbirth2026
Risk of miscarriage after benzodiazepine use during pregnancy: updated systematic review and meta-analysis.
Synthesis in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBenzodiazepine use during pregnancy remains common despite guidelines discouraging it, except for short-term treatment of severe anxiety or agitation. Previous studies have suggested an increased risk of miscarriage after in utero exposure, raising concern at the European level. However, the most recent meta-analysis, published in 2020, included neither several large-scale observational studies nor an assessment by specific benzodiazepine agents. This study aimed to provide an updated synthesis of evidence on the association between early pregnancy exposure to benzodiazepines and miscarriages (excluding studies exclusively involving women with epilepsy), including agent-specific analyses.
methodsA systematic review and meta-analysis were conducted according to Cochrane recommendations. Eligible studies evaluated the association between benzodiazepine use during pregnancy and miscarriage (pregnancy loss before 22 weeks of gestation); studies limited to women with epilepsy were excluded. Risk of bias was assessed using ROBINS-I. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using a random-effects model. Publication bias, heterogeneity, and sensitivity analyses by study design, control group, psychiatric indication and risk of bias were performed. Analyses by specific benzodiazepine agents, dose-response relationships, and E-values for unmeasured confounding were also conducted.
resultsOf 1,142 records screened, ten studies including over 8,000 exposed pregnancies were retained. Benzodiazepine exposure during early pregnancy was associated with a significantly increased risk of miscarriage (pooled OR: 1.68; 95% CI: 1.48-1.90; I² = 60%). After adjusting for publication bias, the association remained (adjusted OR: 1.58; 95% CI: 1.39-1.80). The E-value (2.74) suggested moderate robustness to unmeasured confounding. Sensitivity analyses confirmed the main findings. Pooled ORs for the seven most frequently used agents (e.g., lorazepam, clonazepam, alprazolam) ranged from 1.42 to 1.82, supporting a class effect. All three studies investigating the dose-response relationship found a dose-response trend.
conclusionThis updated meta-analysis indicates that early pregnancy exposure to benzodiazepines is associated with an increased risk of miscarriage. The consistency across analyses and evidence of dose-response strengthen confidence in this association. Clinicians should carefully weigh risks and benefits, consider non-pharmacological alternatives, and ensure close monitoring when prescribing benzodiazepines to women of childbearing potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.